DAKAR (Reuters) -A parliamentary committee in Gambia mentioned on Tuesday that India-based drug maker Maiden Prescribed drugs Ltd was liable for the deaths of at the least 70 youngsters from acute kidney harm and known as on the federal government to pursue authorized motion.
Maiden’s managing director, Naresh Kumar Goyal, didn’t instantly reply to calls and messages from Reuters on Tuesday.
The World Well being Group in October mentioned 4 medicinal syrups made by Maiden and imported by a neighborhood wholesaler have been probably linked to the deaths, which have shocked the West African nation since July. The medication have been pulled from the cabinets and Maiden’s manufacturing licence in India was suspended.
After its investigation, Gambia’s choose committee on well being reached the same conclusion.
Political Cartoons on World Leaders
“All of the circumstances of AKI are linked to the consumption of contaminated medical merchandise…manufactured by Maiden Prescribed drugs,” the committee’s chairperson Amadou Camara mentioned in an announcement to parliament.
Goyal on Friday advised Reuters that his firm had carried out no mistaken.
The WHO in October mentioned that lab evaluation confirmed “unacceptable” quantities of diethylene glycol and ethylene glycol within the medicines made by Maiden, which might be poisonous and result in acute kidney harm.
Earlier this month India advised the WHO that assessments of samples from the identical batches of syrups that have been despatched to Gambia have been compliant with authorities specs.
(Reporting by Edward McAllisterAdditional reporting by Krishna DasWriting by Sofia Christensen Enhancing by Jon Boyle)
Copyright 2022 Thomson Reuters.